Sprifermin

Generic Name: Sprifermin

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: 890058-52-3

Unique Ingredient Identifier: UEJ4E476ZP

Background: Sprifermin has been used in trials studying the treatment of Osteoarthritis, Knee and Cartilage Injury of Knee.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee

Phase 2

Completed

Conditions: Osteoarthritis, Knee

Interventions: Drug: Placebo
Drug: Sprifermin

First Posted Date: 2013-08-08

Last Posted Date: 2020-07-13

Lead Sponsor: EMD Serono Research & Development Institute, Inc.

Target Recruit Count: 549

Registration Number: NCT01919164

Locations: 🇷🇴
Research site, Bucharest, Romania
🇭🇰
Research Site, Hong Kong, Hong Kong

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy